Cover Image
市場調查報告書

腦脊髓液管理:開發平台分析

Cerebrospinal Fluid Management - Pipeline Review, 2015

出版商 GlobalData 商品編碼 340315
出版日期 內容資訊 英文 65 Pages
訂單完成後即時交付
價格
Back to Top
腦脊髓液管理:開發平台分析 Cerebrospinal Fluid Management - Pipeline Review, 2015
出版日期: 2015年08月24日 內容資訊: 英文 65 Pages
簡介

本報告提供腦脊髓液管理相關開發平台上各種處於開發階段之產品綜合分析,並彙整關乎產品開發的主要企業之評估,臨床實驗趨勢等開發平台概要與臨床實驗資料等資訊。

第1章 目錄

第2章 簡介

第3章 開發中的產品

  • 各開發階段平台
  • 各市場區隔開發平台
  • 各領域開發平台
  • 各法律途徑開發平台
  • 認證預定日別開發平台
  • 進行中的臨床實驗趨勢

第4章 各企業正在開發的開發中產品

  • 腦髓液管理企業:各開發階段平台產品
  • 腦髓液管理:各開發階段平台產品

第5章 企業及產品概要

  • Aqueduct Neurosciences
  • Arkis BioSciences
  • Beckersmith Medical, Inc.
  • Biosan Medical Ltd.
  • Ceremed, Inc.
  • CSF Therapeutics, Inc.
  • Georgia Institute of Technology
  • H-Cubed Inc.
  • Integra LifeSciences Holdings Corporation
  • InVivo Therapeutics Corporation
  • Kerecis ehf
  • Microbot Medical, Ltd.
  • Nanonerve Inc.
  • NexGen Medical Systems, Inc.
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • System Science Inc.
  • University Hospital Zurich
  • University of Colorado
  • University of Rochester
  • University of South Florida
  • University of Wisconsin Madison
  • Vivonics, Inc.
  • Wayne State University

第6章 近幾年趨勢

第7章 附錄

圖表

目錄
Product Code: GDME0055EPD

GlobalData's Medical Devices sector report, "Cerebrospinal Fluid Management - Pipeline Review, 2015" provides an overview of Cerebrospinal Fluid Management products currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cerebrospinal Fluid Management pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cerebrospinal Fluid Management products under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cerebrospinal Fluid Management products and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cerebrospinal Fluid Management products under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Cerebrospinal Fluid Management Overview

3. Products under Development

  • 3.1. CSF Management - Pipeline Products by Stage of Development
  • 3.2. CSF Management - Pipeline Products by Segment
  • 3.3. CSF Management - Pipeline Products by Territory
  • 3.4. CSF Management - Pipeline Products by Regulatory Path
  • 3.5. CSF Management - Pipeline Products by Estimated Approval Date
  • 3.6. CSF Management - Ongoing Clinical Trials

4. CSF Management - Pipeline Products under Development by Companies

  • 4.1. CSF Management Companies - Pipeline Products by Stage of Development
  • 4.2. CSF Management - Pipeline Products by Stage of Development

5. CSF Management Companies and Product Overview

  • 5.1. Aqueduct Neurosciences Company Overview
    • 5.1.1. Aqueduct Neurosciences Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Arkis BioSciences Company Overview
    • 5.2.1. Arkis BioSciences Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Beckersmith Medical, Inc. Company Overview
    • 5.3.1. Beckersmith Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Biosan Medical Ltd. Company Overview
    • 5.4.1. Biosan Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Ceremed, Inc. Company Overview
    • 5.5.1. Ceremed, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. CSF Therapeutics, Inc. Company Overview
    • 5.6.1. CSF Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Georgia Institute of Technology Company Overview
    • 5.7.1. Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. H-Cubed Inc. Company Overview
    • 5.8.1. H-Cubed Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Integra LifeSciences Holdings Corporation Company Overview
    • 5.9.1. Integra LifeSciences Holdings Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. InVivo Therapeutics Corporation Company Overview
    • 5.10.1. InVivo Therapeutics Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Kerecis ehf Company Overview
    • 5.11.1. Kerecis ehf Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Microbot Medical, Ltd. Company Overview
    • 5.12.1. Microbot Medical, Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Nanonerve Inc. Company Overview
    • 5.13.1. Nanonerve Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. NexGen Medical Systems, Inc. Company Overview
    • 5.14.1. NexGen Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
    • 5.15.1. Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. System Science Inc. Company Overview
    • 5.16.1. System Science Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. University Hospital Zurich Company Overview
    • 5.17.1. University Hospital Zurich Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. University of Colorado Company Overview
    • 5.18.1. University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. University of Rochester Company Overview
    • 5.19.1. University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. University of South Florida Company Overview
    • 5.20.1. University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. University of Wisconsin Madison Company Overview
    • 5.21.1. University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. Vivonics, Inc. Company Overview
    • 5.22.1. Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. Wayne State University Company Overview
    • 5.23.1. Wayne State University Pipeline Products & Ongoing Clinical Trials Overview

6. CSF Management- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: CSF Management - Pipeline Products by Stage of Development
  • Table 2: CSF Management - Pipeline Products by Segment
  • Table 3: CSF Management - Pipeline Products by Territory
  • Table 4: CSF Management - Pipeline Products by Regulatory Path
  • Table 5: CSF Management - Pipeline Products by Estimated Approval Date
  • Table 6: CSF Management - Ongoing Clinical Trials
  • Table 7: CSF Management Companies - Pipeline Products by Stage of Development
  • Table 8: CSF Management - Pipeline Products by Stage of Development
  • Table 9: Aqueduct Neurosciences Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Smart External Drainage System - Product Status
  • Table 11: Smart External Drainage System - Product Description
  • Table 12: Smart Shunt - Product Status
  • Table 13: Smart Shunt - Product Description
  • Table 14: Arkis BioSciences Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: AutoShunt - Product Status
  • Table 16: AutoShunt - Product Description
  • Table 17: Beckersmith Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 18: FlowSafe - Product Status
  • Table 19: FlowSafe - Product Description
  • Table 20: Biosan Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: Ventritek105 - Product Status
  • Table 22: Ventritek105 - Product Description
  • Table 23: Ceremed, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: Dural Repair System - Product Status
  • Table 25: Dural Repair System - Product Description
  • Table 26: CSF Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: CSF Therapeutic Device - Product Status
  • Table 28: CSF Therapeutic Device - Product Description
  • Table 29: Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
  • Table 30: Hydrocephalus Shunt - Product Status
  • Table 31: Hydrocephalus Shunt - Product Description
  • Table 32: H-Cubed Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: Ambulatory System For Hydrocephalus Shunt - Product Status
  • Table 34: Ambulatory System For Hydrocephalus Shunt - Product Description
  • Table 35: Integra LifeSciences Holdings Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: Hydrocephalic Shunt - Product Status
  • Table 37: Hydrocephalic Shunt - Product Description
  • Table 38: Next Generation DuraGen - Product Status
  • Table 39: Next Generation DuraGen - Product Description
  • Table 40: Next Generation DuraSeal - Product Status
  • Table 41: Next Generation DuraSeal - Product Description
  • Table 42: Ventricular Drainage Device - Product Status
  • Table 43: Ventricular Drainage Device - Product Description
  • Table 44: InVivo Therapeutics Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 45: DuraGraft - Product Status
  • Table 46: DuraGraft - Product Description
  • Table 47: InVivo Therapeutics Corporation - Ongoing Clinical Trials Overview
  • Table 48: DuraGraft - A Study to Evaluate the Use of SOMVC001 (GALA) Vascular Conduit Preservation Solution in Patients Undergoing Coronary Artery Bypass Grafting (CABG)
  • Table 49: Kerecis ehf Pipeline Products & Ongoing Clinical Trials Overview
  • Table 50: Kerecis Omega3 Dura - Product Status
  • Table 51: Kerecis Omega3 Dura - Product Description
  • Table 52: Microbot Medical, Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 53: Microbot Self-Cleaning Shunt (SCS) device - Product Status
  • Table 54: Microbot Self-Cleaning Shunt (SCS) device - Product Description
  • Table 55: Nanonerve Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 56: Nanofibrous Dural Substitute - Product Status
  • Table 57: Nanofibrous Dural Substitute - Product Description
  • Table 58: NexGen Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: EViTAR FLOWMETER - Product Status
  • Table 60: EViTAR FLOWMETER - Product Description
  • Table 61: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
  • Table 62: Bovine Pericardium - Dura Substitute - Product Status
  • Table 63: Bovine Pericardium - Dura Substitute - Product Description
  • Table 64: System Science Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 65: Acute Cerebrospinal Fluid Monitor And Control System - Product Status
  • Table 66: Acute Cerebrospinal Fluid Monitor And Control System - Product Description
  • Table 67: Implantable Cerebrospinal Fluid Monitor And Control System - Product Status
  • Table 68: Implantable Cerebrospinal Fluid Monitor And Control System - Product Description
  • Table 69: University Hospital Zurich Pipeline Products & Ongoing Clinical Trials Overview
  • Table 70: SmartShunt - Product Status
  • Table 71: SmartShunt - Product Description
  • Table 72: University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
  • Table 73: Neural Shunt - Product Status
  • Table 74: Neural Shunt - Product Description
  • Table 75: University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
  • Table 76: Catheterless Shunt System - Product Status
  • Table 77: Catheterless Shunt System - Product Description
  • Table 78: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
  • Table 79: Shunt Catheter System With Inline Filter - Product Status
  • Table 80: Shunt Catheter System With Inline Filter - Product Description
  • Table 81: Sonic Window Cranioplasty Implant - Product Status
  • Table 82: Sonic Window Cranioplasty Implant - Product Description
  • Table 83: University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview
  • Table 84: Gravity And Pressure Controlled Valve System - Product Status
  • Table 85: Gravity And Pressure Controlled Valve System - Product Description
  • Table 86: Hydrocephalus Stent - Product Status
  • Table 87: Hydrocephalus Stent - Product Description
  • Table 88: Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 89: Micro Fabricated Implantable Flowmeter - Cerebrospinal Fluid (CSF) Shunt - Product Status
  • Table 90: Micro Fabricated Implantable Flowmeter - Cerebrospinal Fluid (CSF) Shunt - Product Description
  • Table 91: Wayne State University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 92: Programmable Antisiphon Shunt System - Product Status
  • Table 93: Programmable Antisiphon Shunt System - Product Description
  • Table 94: Glossary

List of Figures

  • Figure 1: CSF Management - Pipeline Products by Stage of Development
  • Figure 2: CSF Management - Pipeline Products by Segment
  • Figure 3: CSF Management - Pipeline Products by Territory
  • Figure 4: CSF Management - Pipeline Products by Regulatory Path
  • Figure 5: CSF Management - Pipeline Products by Estimated Approval Date
  • Figure 6: CSF Management - Ongoing Clinical Trials
Back to Top